(19)
(11) EP 4 771 137 A1

(12)

(43) Date of publication:
08.07.2026 Bulletin 2026/28

(21) Application number: 24861062.8

(22) Date of filing: 29.08.2024
(51) International Patent Classification (IPC): 
C12N 9/10(2006.01)
C12N 9/22(2006.01)
C07K 14/47(2006.01)
(52) Cooperative Patent Classification (CPC):
C12N 9/22; C12N 9/1007; C12Y 201/01037; C07K 2319/09; C07K 2319/80; C12N 2310/20; C07K 14/705; C12N 15/1138
(86) International application number:
PCT/US2024/044497
(87) International publication number:
WO 2025/049789 (06.03.2025 Gazette 2025/10)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 01.09.2023 US 202363580330 P
09.11.2023 US 202363597676 P

(71) Applicant: nChroma Bio, Inc.
Boston, MA 02215 (US)

(72) Inventors:
  • COLLINS, McKensie, Alexis
    Boston, MA 02215 (US)
  • FRIEDLAND, Ari
    Boston, MA 02215 (US)
  • JAFFE, Aron, Brandon
    Boston, MA 02215 (US)
  • MYER, Vic
    Boston, MA 02215 (US)
  • RAMIREZ, Ricardo, Noel
    Boston, MA 02215 (US)
  • SCHAFER, Jamie, Lynn
    Boston, MA 02215 (US)

(74) Representative: Hoffmann Eitle 
Patent- und Rechtsanwälte PartmbB Arabellastraße 30
81925 München
81925 München (DE)

   


(54) COMPOSITIONS AND METHODS FOR EPIGENETIC REGULATION OF ADORA2A EXPRESSION